Toulouse Breakthrough: Pioneering Combined Kidney-Islet Transplant Opens New Doors for Diabetics
In a landmark achievement, the University Hospital of Toulouse (CHU de Toulouse) has successfully performed France’s first simultaneous kidney and islet transplant using a single Maastricht 3 donor. This innovative procedure, announced on March 9, 2026, offers renewed hope for patients with type 1 diabetes and chronic kidney failure, particularly those for whom traditional combined kidney-pancreas transplants are not viable due to vascular constraints.
The Challenge of Complex Cases
The patient, suffering from type 1 diabetes complicated by advanced kidney failure requiring dialysis, presented a unique challenge. Major vascular constraints precluded a standard kidney-pancreas transplant. The CHU de Toulouse team devised an innovative approach: a kidney transplant to halt dialysis, coupled with an islet transplant to improve blood sugar control and protect the newly transplanted kidney from diabetes-related damage.
Maastricht 3 Donors: Expanding the Possibilities
The success hinges on utilizing a Maastricht 3 donor – an individual who died after cardiac arrest following a decision to withdraw life support. This donor type presents logistical and medical complexities, as organs experience a period of reduced blood flow after death. Though, advancements in organ preservation techniques are making these donors increasingly viable.
New Techniques in Organ Preservation
The increasing employ of techniques like regional normothermic perfusion, which temporarily restores blood flow to organs, and artificial perfusion devices, which deliver nutrient and oxygen-rich fluids, are crucial in maximizing the potential of organs from Maastricht 3 donors. These methods are extending the window of opportunity for transplantation and increasing the number of available organs.
A Growing Trend: Donation After Circulatory Death
The use of donors after circulatory death (DCD), like the Maastricht 3 donor, is a growing trend globally. In the United States, DCD donors have risen from 2% of all donors in 2000 to 49% in 2025, reaching 73% in some regions. This shift is driven by the increasing demand for organs and the development of improved preservation technologies.
Recent Regulatory Changes
Recent regulatory changes in France, formalized in a decree published in the Journal officiel, now authorize heart retrieval from Maastricht 3 donors, alongside kidneys, livers, lungs, and pancreases. This expands the potential for life-saving transplants and reflects a growing acceptance of DCD as a valuable source of organs.
The Future of Islet Transplantation
Islet transplantation, the second component of this groundbreaking procedure, involves transplanting insulin-producing cells (islets of Langerhans) to improve glycemic control. For type 1 diabetes patients, these cells have been destroyed by the immune system. Successful islet transplantation can reduce or even eliminate the demand for insulin injections.
Coordination is Key
This complex procedure required close coordination between multiple teams. The pancreas from the donor was sent to the CHU of Montpellier for islet preparation, while surgeons at the CHU de Toulouse performed the kidney transplant. A radiology team then injected the islets into the patient’s liver.
FAQ
Q: What is a Maastricht 3 donor?
A: A Maastricht 3 donor is someone who died after cardiac arrest following a decision to withdraw life support.
Q: What are islets of Langerhans?
A: These are clusters of cells in the pancreas that produce insulin, regulating blood sugar levels.
Q: Why is this transplant considered innovative?
A: It’s the first time in France a simultaneous kidney and islet transplant has been performed using a Maastricht 3 donor.
Q: What are the benefits of this approach?
A: It offers a viable option for patients with complex medical conditions who are not candidates for traditional kidney-pancreas transplants.
Did you know? The success of this procedure relies on a delicate balance of medical expertise, logistical coordination, and advancements in organ preservation techniques.
Pro Tip: Staying informed about advancements in organ transplantation can empower patients and their families to explore all available treatment options.
Learn more about organ donation and transplantation at CHU de Toulouse.
Have questions about this groundbreaking procedure? Share your thoughts in the comments below!
